+34 656 7900
L - J: 08:30 - 17:30 | V: 8:30 - 14:30
info@histocell.com
CONTACTO
EN
ES
Histocell Regenerative MedicineHistocell Regenerative MedicineHistocell Regenerative Medicine
  • Home
  • Cell Therapy and Biologic Medicinal Products
  • Wound Healing
  • Dermo-cosmetics
  • R&D
  • News
  • News
    17/01/202317/01/2023 Histocell takes part in the new European project NABIHEAL in biomaterials for complex wound healing
    The Horizon Europe project NABIHEAL, coordinated by the Center for Biomedical Research Network (CIBER) at...
    Read more
    By  administrador
  • News
    23/11/202228/12/2022 Japanese company REPROCELL invests in Histocell
    REPROCELL Inc. decided to invest in Histocell S.L. to strengthen its clinical induced pluripotent stem...
    Read more
    By  administrador
  • News
    17/11/202222/11/2022 Histocell inaugurates new manufacturing plant for advanced therapy medicinal products
    Histocell has inaugurated this morning its manufacturing plant in Larrabetzu, dedicated to cell therapy and...
    Read more
    By  administrador
  • News
    31/05/202124/11/2022 Cardiva expands its business by acquiring a stake in the biopharmaceutical company Histocell
    The company has decided to join one of the most renowned Spanish companies in the...
    Read more
    By  administrador
  • News
    08/02/202124/11/2022 Histocell and Cardiva join forces to introduce the innovative wound care product Reoxcare throughout the Spanish healthcare system.
    The Basque biopharmaceutical company Histocell and the company Cardiva join forces to introduce the innovative...
    Read more
    By  administrador
  • News
    10/01/202124/11/2022 Technological cosmetics
    TEKNOPOLIS - EITB The Basque company Histocell researches the world of dermocosmetics, bringing together medicine...
    Read more
    By  administrador
  • News
    17/12/202024/11/2022 Histocell successfully completes the clinical safety phase of its cell therapy drug HC016 for the treatment of acute respiratory distress caused by covid-19
    Histocell has successfully completed phase I of the clinical trial of the cell therapy drug...
    Read more
    By  administrador
  • News
    01/09/202024/11/2022 Histocell joins forces with seven companies in the Bio-Health area to launch the IMABI project
    Eight Basque companies, as well as various agents of the Basque Science, Technology and Innovation...
    Read more
    By  administrador

Entradas recientes

  • Histocell takes part in the new European project NABIHEAL in biomaterials for complex wound healing
  • Japanese company REPROCELL invests in Histocell
  • Histocell inaugurates new manufacturing plant for advanced therapy medicinal products
  • Cardiva expands its business by acquiring a stake in the biopharmaceutical company Histocell
  • Histocell and Cardiva join forces to introduce the innovative wound care product Reoxcare throughout the Spanish healthcare system.

Comentarios recientes

No comments to show.

Archivos

  • January 2023
  • November 2022
  • May 2021
  • February 2021
  • January 2021
  • December 2020
  • September 2020

Categorías

  • News
  • Sin categorizar
Histocell
  • Home
  • Cell Therapy and Biologic Medicinal Products
  • Wound Healing
  • Dermo-cosmetics
  • R&D
  • News
Contacta con nosotros/as
  • +34 94 656 7900
  • info@histocell.com